Numaswitch: an efficient high-titer expression platform to produce peptides and small proteins
Abstract The production of peptides as active pharmaceutical ingredients (APIs) by recombinant technologies is of emerging interest. A reliable production platform, however, is still missing due the inherent characteristics of peptides such as proteolytic sensitivity, aggregation and cytotoxicity. W...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2021-03-01
|
Series: | AMB Express |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13568-021-01204-w |